Annual Irish Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy Symposium

We are delighted to announce

The Annual Irish Radiosurgery and Stereotactic Ablative Radiotherapy Symposium

will take place on 28th – 29th May 2018, at Convention Centre Dublin,

Starting 2018, this event is jointly organized by Beacon Hospital, St Luke’s Institute of Cancer Research and Hermitage Medical Clinic. This symposium aims to increase the awareness and knowledge of the indications and techniques of intra-cranial SRS and extra-cranial SBRT, at a time when an expansion of SRS/SBRT activity is planned across Ireland and the European Continent. This two day, fully interactive educational program will cover some of the fundamentals and advanced concepts of SRS/SBRT, technological challenges, quality assurance and patient safety, and the present and future clinical applications. Interactive workshops on treatment planning, respiratory motion analysis and multimodality imaging for intra-cranial planning will be run during the symposium.

The symposium faculty has significant links with the academic and research world, both nationally and internationally, as well as Trans-European experience.  The target audience includes Radiation Oncologists, Medical Physicists, Radiation Therapists, and allied health professionals, as well as Neurosurgeons, Medical Oncologists and Researchers.

Applications were made for ESTRO endorsement and EACCME accreditation

Places are limited.

Kind Regards,

Alina Mihai MD MSc

Symposium Director

on behalf of the Scientific and Organizing Committee

of the Irish Annual SRS/SABR Symposium

Agenda Day 1 - 28th

Agenda Day 2 - 29th

Dr.Alina Mihai

Consultant Radiation Oncologist



Dr. Alina Mihai is full time Consultant Radiation Oncologist at  Beacon Hospital, with expertise in high technology such as IMRT and stereotactic radiosurgery and stereotactic body radiotherapy.  Dr. Mihai earned her Medical Degree and Specialty in Romania. Her training included clinical and research Fellowships in France (University of Rouen –Prof B.Dubray), and Canada.  Between 2002-2005 at University of Toronto, where she was involved in  development of forward planning IMRT for breast cancer and in assessing the role of central pathology review in DCIS breast. Between 2006-2007 Dr Mihai joined the staff of the Radiotherapy Department of the Cross Cancer Institute Edmonton (Alberta), initially as a Clinical Research fellow, subsequently as a full time locum Consultant. During this period she was involved in developing the tomotherapy technique for breast cancer treatments, as well as in implementing the PET-CT and myocardial perfusion scans in the process of radiotherapy planning for lung and breast malignancies.

Dr Mihai joined UPMC Beacon Hospital in July 2007.  She has had a pivotal role in implementation and development of gated and image guided radiotherapy and stereotactic body radiotherapy at Beacon Hospital . Her expertise is in assessment of moving targets, SBRT for oligometastatic disease and IMRT for brain, prostate and lung cancers. In addition, she is actively involved in the development of UPMC pathways for therapeutic management of rectal, oesophageal and prostate cancers. She organised and leads the extracranial SBRT task group at Beacon Hospital. Dr Mihai earned her Master degree in Radiation Science (University of Toronto) in 2006.

Her present areas of research and publications include:

  • SBRT for oligometastatic disease
  • SBRT in elderly
  • role of metabolic imaging in treatment planning and response assessment

She is member of several professional organizations including ICORG, ESTRO, ASTRO, EANO. She is site principal investigator in two clinical trials opened at Beacon Hospital and co-investigator in other two.

clinical lead st luke’s ratiation oncology network beaumont hospital

Clare Faul

Clinical lead St Luke’s ratiation oncology network Beaumont Hospital


Clinical lead st luke’s ratiation oncology network beaumont hospital

Prof John Armstrong

Director of Research at St. Luke’s Hospital


Professor John Armstrong is a Board Member and ex-chairman of the Irish Cancer Society. Professor Armstrong was trained at Memorial Sloan-Kettering Cancer Center, where he performed his residency and was Chief resident, attending for five years. He directed the lung cancer radiation research programme at Memorial Sloan-Kettering Cancer Center, and co-authored the chapter on non-small cell lung cancer chapter in 4th edition of DeVita, Hellman, and Rosenberg, Cancer: Principles and Practice of Oncology, Lippincott.

He is currently the Director of Research at St. Luke’s Hospital, Dublin. Professor Armstrong is the Principal Investigator for several clinical trials in the Irish Clinical Oncology Research Group.

Professor Armstrong has published numerous articles and has lectured extensively in the field of radiation oncology. He has been instrumental in the rollout of new procedures involving high-tech radiation therapy procedures such as Intensity Modulated Radiation Therapy, and stereotactic radiosurgery




I have as strong interest in radiation treatment of brain tumors and in radiosurgery. I helped establish the first Gamma Knife radiosurgery center in the United States at UPMC Presbyterian in 1987 and have continued to direct the radiation oncology component of our Gamma Knife center there.

Teaching medical students and residents in their radiation oncology rotations

Professor Dirk VERELLEN, PhD



Qualifications / education:
PhD Medical Sciences, Vrije Universiteit Brussel (VUB), 1998
Qualified Medical Physicist, Radiation Oncology, 1991
MSc Physics, Antwerp University, 1989
Aggregated for higher secondary education, 1989
Main areas of professional interest/specialisation:
The practical issues concerning implementation of high precision conformal radiotherapy
and image-guidance in a clinical environment.
Establishing a safety culture in radiation oncology.
Professional experience/appointments:
Professor Biomedical Physics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel,
from 2003.
Head of Medical Physics, Radiation Oncology, UZ Brussel, from 1996
Qualified Medical Physicist, Radiation Oncology, UZ Brussel, 1991-1995

Call for Abstracts. Exhibit your Poster
The Future of Health Care – Collaboration is key to Excellence in Healthcare


Annual Irish Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy Symposium


Call for Abstracts The Scientific Committee of the 6th International SRS/SBRT symposium are pleased to announce the 2018 SRS/SBRT Young Investigator’s Awards. We are now calling for abstracts The Young Investigator’s Award is open to young professionals (physicians, residents, physicists, and therapists) working in the field of radiotherapy/stereotactic radiosurgery. Six finalists will be selected from the abstracts for poster discussion at the 2018 Young Investigator Awards held during the 6th  International SRS/SBRT Symposium. The presentations will be judged and awards presented at the end of the meeting. Interested candidates should submit via the form below, we will be in-touch shortly

Benefits of Submitting to this International Event

1) All applicants receive a promotional code discount for the Future Health Summit.

2) All Abstracts accepted receive a full rebate for booked registrations for the event

3) Get Published in our Abstract Booklet and on our content hub.

4) Display your research to over 2000 attendees at the event

The winners of each category receive a trophy and the Overall winner will receive a monetary prize
The closing date is the Friday the 20th April 2018 and the review process will conclude by Monday 30th April 2018 and presenters should expect to receive feedback on their abstract submission no later than Monday 7th of May 2018.The Judging Review Committee will evaluate submissions for quality, relevance to the conference, theme, clarity, originality and timeliness.

Submit your Abstract Now by completing the form Below


The following information should be included on the abstract:

The title of the abstract and full name of the presenting author and all co- authors separated by commas. Submissions should clearly state the objectives/aims, method, results & conclusions of the study. The abstract should not contain bibliographic references, tables or appendices. The abstract should be approximately 250 words but no more than 500 (count not including title/authors). By submitting your abstract, you are confirming that all authors have approved the submission, and agree to your abstract appearing on our website. All sources of financial sponsorship or support of the study should be stated clearly at the end of the abstract.


For any queries please contact us via mail on or call 00353(01)7008508

Agenda Day 1 - 28th May 2018

Day 2 Agenda 29th May 2018

Symposium Agenda 2017

Symposium Agenda 2016

Platinum Sponsor

Gold Sponsors

Silver Sponsors
back to top